Tesofensine: Product overview
Tesofensine has been studied as a way to treat obesity via its ability to reduce appetite. This molecular compound indirectly stimulates the cholinergic system and showed to be more successful than other weight loss agents. Tesofensine (TE) increases transmission of 3 monoaminergic neurotransmitters in the brain.
Tesofensine is a serotonin-noradrenaline-dopamine reuptake inhibitor which was originally studied for its effect on Parkinson’s and Alzheimer’s. Unfortunately, its exploration for these indications were limited because the research subjects starting losing too much weight. Since then, tesofensine has been studied as a way to treat obesity via its ability to reduce appetite. This molecular compound indirectly stimulates the cholinergic system and showed to be more successful than other weight loss agents. Tesofensine (TE) increases transmission of 3 monoaminergic neurotransmitters in the brain. These neurotransmitters are serotonin, norepinephrine, and dopamine which help regulate energy balance and are linked to obesity and depression. On average, its 6-month weight loss results from a phase 2b clinical trial resulted in a weight loss of around 25 pounds. TE research has shown a pronounced effect on appetite sensations and a slight effect on energy expenditure. Both effects can contribute to the strong weight reducing
Tesofensine Properties
- Chemical Formula: C17H23Cl2NO
- Molecular Mass: 328.3
- Synonyms: NS-2330, UNII-BLH9UKX9V1, BLH9UKX9V1, ZINC3953158
- CAS Number: 195875-84-4
- PubChem:11370864
- Total Amount of the Active Ingredient: 250 mcg/60 capsules
- Shelf Life: 36 months
Benefits of Tesofensine
- Effective Weight Loss
- Enhanced Energy Balance
- Convenient Dosage
- Multi-Targeted Mechanism
- Product Quality
Lab tests are occasionally published on the website.
You can have the product you bought from us tested at any HPLC-licensed testing facility and if the results are negative, we will refund the following:
- Cost of HPLC test
- Total amount of the order + shipping fee
Peer-Reviewed Studies
Arne Astrup, Dieter H Meier, Birgit O Mikkelsen, John S Villumsen, Thomas M Larsen
The Obesity Society Volume16, Issue6 June 2008 Pages 1363-1369
Disclaimer
The information provided above is not intended to substitute medical advice, diagnosis, or treatment. Should you have any questions regarding a medical condition, seek the advice of your physician or a qualified healthcare provider. Please note that they are being sold for research purposes ONLY.
